Targeting CD24 in Cancer Immunotherapy
Immunotherapy is a hot area in cancer treatment, and one of the keys to this therapy is the identification of the right tumour-associated or tumour-specific antigen. Cluster of differentiation 24 (CD24) is an emerging tumour-associated antigen that is commonly and highly expressed in various tumours...
Main Authors: | Wenwen Chen, Zhigang Hu, Zhigang Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/12/3159 |
Similar Items
-
CD24: A Novel Target for Cancer Immunotherapy
by: Emmanouil Panagiotou, et al.
Published: (2022-07-01) -
Checkpoint CD24 function on tumor and immunotherapy
by: Shiming Huang, et al.
Published: (2024-02-01) -
Targeting the CD24-Siglec10 Axis: A Potential Strategy for Cancer Immunotherapy
by: Junyue Fang, et al.
Published: (2024-02-01) -
The biological roles of CD24 in ovarian cancer: old story, but new tales
by: Yuanyuan Gu, et al.
Published: (2023-06-01) -
Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10
by: Shan-Shan Yin, et al.
Published: (2020-07-01)